News 20 June 2019

GLP-1 receptor agonist lowers CVD and renal risk: study

In the longest trial yet of a glucagon-like peptide 1 (GLP-1) receptor agonist, dulaglutide has been shown to reduce major adverse events when added to usual therapies for patients with type 2 diabetes and cardiovascular disease or CVD risk factors.
Specialist Update 18 June 2019 Clare Pain

GLP-1 receptor agonist lowers CVD and renal risk: study

In the longest trial yet of a glucagon-like peptide 1 (GLP-1) receptor agonist, dulaglutide has been shown to reduce major adverse events when added to usual therapies for patients with type 2 diabetes and cardiovascular disease or CVD risk factors.
Specialist Update 18 June 2019 Kemal Atlay

Half of thyroid ultrasound requests are 'inappropriate', study finds

About half of thyroid ultrasound imaging requests in patients with suspected thyroid nodules are performed outside of expert recommendations, an Australian study has found.
Specialist Update 17 June 2019 Reuters Health

Fracture-risk reduction 'continues with long-term denosumab'

Extended treatment with denosumab is associated with continued reduction in non-vertebral fracture rates, according to findings from an extension of a clinical trial.
News 17 June 2019

Diabetes: tight control has 'diminishing returns' on CV risks

Intensive glucose-lowering in older patients with advanced type 2 diabetes is unlikely to confer lasting cardiovascular benefits or reduce mortality risk compared with standard treatment, a major US trial has shown.
How to Treat 14 June 2019 Mahnaz Bahri Khomami, Dr Soulmaz Shorakae, Professor Helena Teede
News 13 June 2019 Kemal Atlay

Diabetes: tight control has 'diminishing returns' on CV risks

Intensive glucose-lowering in older patients with advanced type 2 diabetes is unlikely to confer lasting cardiovascular benefits or reduce mortality risk compared with standard treatment, a major US trial has shown.
News 12 June 2019 Reuters Health

Is there a link between too much sleep and diabetes?

Sleeping too much, as well as too little, is tied to high blood sugar levels, not just in people with diabetes but also in those at high risk for developing the disease, a study finds.
Specialist Update 03 June 2019 Kemal Atlay

Subclinical hypothyroidism guidelines 'not supported by evidence', critics say

A spat has erupted over new practice guidelines that advise against prescribing thyroid hormone replacement therapy for adults with subclinical hypothyroidism.
Specialist Update 03 June 2019 Clare Pain

Do children's bones at age three reflect mum's vitamin D?

The length of children’s long bones at age three is determined, not by maternal vitamin D or mother or child’s diet, but simply by genetics, a study suggests.